002800 — Sinsin Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Sinsin Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	201	-1,449	4,355	4,646	4,811
Depreciation
Amortisation
Non-Cash Items	-3,254	2,244	2,394	3,577	4,641
Unusual Items
Other Non-Cash Items
Changes in Working Capital	2,334	-4,443	-5,046	-8,231	-7,769
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,865	23.2	5,461	3,930	5,943
Capital Expenditures	-12,153	-2,682	-1,042	-5,027	-1,515
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	20,784	30.4	-103	-1,024	-4,043
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	8,630	-2,652	-1,145	-6,051	-5,557
Financing Cash Flow Items	—	35	—	70	0
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	-9,086	925	-2,825	226	-208
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,374	-1,705	1,441	-1,894	193